The Inactivated Vaccines Market is evolving as manufacturers focus on production efficiency, supply chain resilience, and improved vaccine formulations. However, complex manufacturing requirements, regulatory compliance, storage conditions, and distribution costs remain important considerations for market participants. The Inactivated Vaccines Market was valued at US$ 24.85 billion in 2025 and...